Trexquant Investment’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$512K	Buy	+25,527	New	+$512K	0.01%	1259
2021 Q4	–	Sell	-4,912	Closed	-$80K	–	1380
2021 Q3	$80K	Buy	+4,912	New	+$80K	0.01%	1067